A new Fujirebio Diagnostics blood test identifies beta-amyloid, a brain plaque that is a key marker for Alzheimer’s disease.

New Mexico has paired up with the Alzheimer’s Association in a pilot U.S. initiative aimed at raising awareness about a disease that affects several million people in the country.

Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after an independent watchdog agency said the treatment isn’t worth the cost to taxpayers.

Thousands were in attendance to support Broward County's Walk to End Alzheimer's on Saturday.

More than 3,000 participants came out on Saturday morning for the Alzheimer’s Association Walk to End Alzheimer’s at Florida International University.

The Alzheimer's Brain Bus is out on the road and it's going to be part of a bilingual community event.

Medicare recipients will get a premium reduction — but not until next year.

Dr. James Galvin, the Director of the University of Miami Miller School of Medicine’s Comprehensive Center for Brain Health, describes how the new center’s goal is to better treat and prevent degenerative brain diseases like Alzheimer’s and Lewy Body Dementia through research studies and seeing patients. Bobbi Rutt is one of those patients.

The annual event raises hundreds of thousands of dollars for Alzheimer's research.

The acting head of the Food and Drug Administration is calling for a government investigation into highly unusual contacts between her agency’s drug reviewers and the maker of a controversial new Alzheimer’s drug.

Government health officials have approved the first drug that they say may help slow Alzheimer’s disease.

(CNN) - A new study finds personalized lifestyle interventions not only stopped cognitive decline in people at risk for Alzheimer's, but actually increased their memory and thinking skills within 18 months. "This is the first study in a real-world clinic setting showing individualized clinical management may improve cognitive function and also reduce Alzheimer's and cardiovascular risk," Isaacson said. The study was published Wednesday in the journal "Alzheimer's and Dementia: The Journal of the Alzheimer's Association." "Our study was designed to look at the effects of lifestyle intervention on cognitive function," Isaacson said. The study was not designed to prevent Alzheimer's, only to see if lifestyle changes affected cognitive function.

Subjects were randomized to 12 months of aerobic exercise or stretching and toning. Both aerobic and stretching may prevent or slow cognitive decline, according to the researchers, but aerobic exercise had more benefits on reducing hippocampal shrinkage than stretching. But MRI and PET imaging showed those who did aerobic exercise had slower degeneration in the hippocampus than those who did flexibility training. "The brains of participants with amyloid responded more to the aerobic exercise than the others," Zhang said. "Most physicians believe in the power of exercise to support overall brain health, but fewer believe that exercise can specifically impact people with early Alzheimer's," Isaacson said.